Multiple cell-surface receptors and membrane components

Multiple cell-surface receptors and membrane components is a broad pharmacological designation rather than a single, discrete molecular target. It encompasses the diverse array of proteins, lipids, and carbohydrates that constitute the cellular plasma membrane, which serves as the primary interface for signal transduction and environmental interaction (Source: Molecular Biology of the Cell, Alberts et al.). Drugs mapped to this category often exhibit polypharmacology, meaning they interact with several different receptors or structural components at once to achieve a therapeutic effect. For example, general anesthetics like sevoflurane are thought to act on multiple ion channels and the lipid matrix itself to induce unconsciousness (Source: StatPearls, General Anesthesia). Similarly, certain antimicrobial agents like Colistin or Amphotericin B target conserved membrane features to disrupt the integrity of pathogen cells (Source: PubMed, PMID: 25130017). Because this classification lacks a specific genetic or structural identity, it is primarily used in drug discovery to describe agents with complex, multi-faceted, or poorly defined surface-level mechanisms of action. Consequently, developing drugs for this target presents significant challenges in achieving selectivity and minimizing adverse effects on healthy host tissues (Source: Goodman & Gilman's The Pharmacological Basis of Therapeutics).

Other names

Cell surface componentsMembrane-associated targetsNon-specific membrane interactionsPlasma membrane components

Drugs associated with this category typically function through non-specific physical or chemical interactions with the lipid bilayer or by modulating the activity of multiple surface proteins simultaneously (Source: StatPearls, General Anesthesia). This can include the formation of transmembrane pores, alteration of membrane fluidity, or competitive binding across various receptor classes (Source: PubChem, Amphotericin B).